Whole brain imaging of HIV-infected patients: quantitative analysis of magnetization transfer ratio histogram and fractional brain volume.

BACKGROUND AND PURPOSE Magnetization transfer ratio (MTR) histogram analysis and volumetric MR imaging are sensitive tools with which to quantify the tissue destructive effects in patients with white matter or neurodegenerative disease. Our purpose was to determine whether whole brain MTR and fractional brain parenchyma volume measurements are altered in HIV-1-infected patients who are neurologically symptomatic and in those who are asymptomatic. METHODS We performed MR imaging and MTR studies of 15 neurologically symptomatic (seven patients) and asymptomatic (eight patients) HIV-1-seropositive patients and compared their findings with those of 10 seronegative normal control participants. MTR was computed on the basis of whole brain parenchyma segmented by using thin section dual echo MR images. RESULTS The loss of brain tissue, indicated by fractional brain parenchyma volume, was more pronounced in neurologically symptomatic patients (P =.003) but not in asymptomatic patients (P =.23) when compared with control participants. As for whole brain MTR histogram analysis, both patient groups showed significant decrease in mean (P =.02) and median (P < or =.009) values, compared with normal control participants. There was a trend toward positive correlation (r > or = 0.56) between MTR histogram statistics and fractional brain parenchyma volume. CONCLUSION Our results suggest that MTR histogram analysis is sensitive in detecting early involvement in neurologically asymptomatic patients with HIV and may, therefore, be used as a combined tool with volumetric measurement, which showed significant tissue loss only in symptomatic patients, to assess various stages of brain damage induced by HIV.

[1]  Dewey Odhner,et al.  3DVIEWNIX: an open, transportable, multidimensional, multimodality, multiparametric imaging software system , 1994, Medical Imaging.

[2]  M Filippi,et al.  Magnetization transfer changes in the normal appering white matter precede the appearance of enhancing lesions in patients with multiple sclerosis , 1998, Annals of neurology.

[3]  Supun Samarasekera,et al.  Multiple sclerosis lesion quantification using fuzzy-connectedness principles , 1997, IEEE Transactions on Medical Imaging.

[4]  L. Mucke,et al.  Pathogenesis of HIV-1 associated neurodegeneration. , 1996, Critical reviews in neurobiology.

[5]  G. D. Pearlson,et al.  Reduced basal ganglia volume in HIV‐1‐associated dementia , 1993, Neurology.

[6]  G. Fein,et al.  Elevated subcortical choline metabolites in cognitively and clinically asymptomatic HIV patients , 1999, Neurology.

[7]  K. Ruxrungtham,et al.  Magnetic resonance spectroscopy of the brain in neurologically asymptomatic HIV-infected patients. , 2000, Magnetic resonance imaging.

[8]  M. Thurnher,et al.  CNS involvement in AIDS: spectrum of CT and MR findings , 1997, European Radiology.

[9]  J K Udupa,et al.  Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: longitudinal quantitative analysis. , 2000, Radiology.

[10]  K. Marder,et al.  A prospective controlled study of magnetic resonance imaging of the brain in gay men and parenteral drug users with human immunodeficiency virus infection. , 1992, Archives of neurology.

[11]  B. Brew,et al.  Quinolinic Acid Production by Macrophages Stimulated with IFN-γ, TNF-α, and IFN-α , 1997 .

[12]  J. Frank,et al.  Relationship of neurologic status in macaques infected with the simian immunodeficiency virus to cerebrospinal fluid quinolinic acid and kynurenic acid , 1992, Brain Research.

[13]  D. Clifford,et al.  White matter lesions and cerebral atrophy on MR images in patients with and without AIDS dementia complex. , 1993, AJR. American journal of roentgenology.

[14]  G. Barker,et al.  Magnetisation transfer of normal appearing white matter in primary progressive multiple sclerosis , 1999, Multiple sclerosis.

[15]  G D Pearlson,et al.  Magnetic resonance imaging measurement of gray matter volume reductions in HIV dementia. , 1995, The American journal of psychiatry.

[16]  Sohil H. Patel,et al.  Correlation between percentage of brain parenchymal volume and neurocognitive performance in HIV-infected patients. , 2002, AJNR. American journal of neuroradiology.

[17]  J. Dartigues,et al.  Magnetization transfer study of HIV encephalitis and progressive multifocal leukoencephalopathy. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine. , 1997, AJNR. American journal of neuroradiology.

[18]  T. Jernigan,et al.  Elevated cerebrospinal fluid quinolinic acid levels are associated with region-specific cerebral volume loss in HIV infection. , 2001, Brain : a journal of neurology.

[19]  C. Achim,et al.  Human immunodeficiency virus encephalitis is the pathological correlate of dementia in acquired immunodeficiency syndrome , 1994, Annals of neurology.

[20]  K. Kieburtz,et al.  Cognitive performance and regional brain volume in human immunodeficiency virus type 1 infection. , 1996, Archives of neurology.

[21]  Supun Samarasekera,et al.  Fuzzy connectedness and object definition , 1995, Medical Imaging.

[22]  T. Jernigan,et al.  Progressive cerebral volume loss in human immunodeficiency virus infection: a longitudinal volumetric magnetic resonance imaging study. HIV Neurobehavioral Research Center Group. , 1998, Archives of neurology.

[23]  T. Stone,et al.  Neuropharmacology of quinolinic and kynurenic acids. , 1993, Pharmacological reviews.

[24]  B. Brew,et al.  Chronic exposure of human neurons to quinolinic acid results in neuronal changes consistent with AIDS dementia complex , 1998, AIDS.

[25]  G. Reynolds,et al.  Deficits of NMDA receptors and glutamate uptake sites in the frontal cortex in AIDS. , 1999, Neuroreport.

[26]  I. Elovaara,et al.  Mild brain atrophy in early HIV infection: the lack of association with cognitive deficits and HIV-specific intrathecal immune response , 1990, Journal of the Neurological Sciences.

[27]  E. Masliah,et al.  Cortical dendritic pathology in human immunodeficiency virus encephalitis. , 1992, Laboratory investigation; a journal of technical methods and pathology.

[28]  J K Udupa,et al.  Global volumetric estimation of disease burden in multiple sclerosis based on magnetization transfer imaging. , 1997, AJNR. American journal of neuroradiology.

[29]  G. B. Pike Ph. D.,et al.  Magnetization transfer imaging of multiple sclerosis , 2005, The Italian Journal of Neurological Sciences.

[30]  S. Lipton,et al.  HIV neurocognitive disorders. , 2005 .

[31]  J. Mazziotta,et al.  MRI‐PET Registration with Automated Algorithm , 1993, Journal of computer assisted tomography.

[32]  R I Grossman,et al.  Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. , 1992, Radiology.

[33]  A. Guimarães,et al.  Brain choline-containing compounds are elevated in HIV-positive patients before the onset of AIDS dementia complex , 1996, Neurology.

[34]  A. Uluğ,et al.  Diffusion tensor imaging of patients with HIV and normal-appearing white matter on MR images of the brain. , 2001, AJNR. American journal of neuroradiology.

[35]  G. Hensley,et al.  MR of Toxoplasma encephalitis: signal characteristics on T2-weighted images and pathologic correlation. , 1996, Journal of computer assisted tomography.

[36]  C A Wiley,et al.  The relationship of quantitative brain magnetic resonance imaging measures to neuropathologic indexes of human immunodeficiency virus infection. , 1994, Archives of neurology.

[37]  Susan Swindells,et al.  The Neurology of AIDS , 1998 .

[38]  O. Selnes,et al.  Human Immunodeficiency Virus-Associated Dementia , 1999, Seminars in neurology.